Like many disruptive technologies, engineered T-cell therapies follow the Gartner hype cycle. We are approaching the second upward slope.

🧬”Leveraging bioengineering to elucidate the crosswalk between the microbiome, musculoskeletal tissues, and cancer progression” Thank you Eva Gonzalez Diaz, Ph.D Eva C. González Díaz, PhD for presenting your work for us! How have you leveraged bioengineering to cure cancer? #CancerResearch

Wanna move CRISPR genome editing to the clinics? Wanna to build tech to tackle the big challenges of cell therapy? 🧬✂️🩸 Join us as a Postdoc at Center for Cell and Gene Therapy BCMHouston - Please RT 🙏 jobs.bcm.edu/job/Postdoctor…

Matt Rea was treated with CD19 CART cells back in 2010 at Baylor Center for Cell and Gene Therapy and has been cancer-free since then, for 14 years. The CAR-T were made from his twin brother. Is he the longest surviving CAR-T patient? blogs.bcm.edu/2024/06/04/fol…

🧬🔬“Developing combination therapies for pediatric brain tumors.” Thank you Jamie Anastas Ph.D for presenting your work in our Work In Progress seminar series! What combination therapies have you found effective in brain tumors? 🧠#CancerResearch

Bispecific Antibodies and Autologous Chimeric Antigen Receptor T cell therapies for Treatment of Hematological Malignancies Molecular Therapy #mmsm #celltherapy #bmtsm #lymsm #leusm UAMS Myeloma Center Center for Cell and Gene Therapy ➡️ cell.com/molecular-ther… Many figures and tables , check few 👇

#CARTcelltherapy for pediatric #brainCancer warrants further study. #Glioma. Drs. B Omer, C Rooney & F Lin explain their findings. Center for Cell and Gene Therapy Texas Children's blogs.bcm.edu/2024/06/18/fro… via BCMHouston

One of my goals has been to share what others have taught me. Patients will have better access and more effective drugs if more of us are innovating and not trying to rediscover the basics. I'm happy to share our most recent Cytotherapy paper where we highlight 10 years of GMP

T cells express a ton of CD5, so why CD5 CAR T cells don't kill each other? Turns out, they completely degrade CD5 protein and thus evade fratricide. Unique mechanism unveiled in a mechanistic study - and PhD thesis work - by Royce Ma: cell.com/cell-reports-m…

Announcing the 2024 SPAI postdoc seminar season BCMHouston. Happy to share that 2 of our inaugural 2023 SPAI speakers are now #newPI. SPAI's vision is to promote the next generation of future faculty who would also be good mentors! Apply by Sept 15th. form.jotform.com/241756255206153

Excited to share our review on CAR-T real-world outcomes: Approved CAR-T therapies have reproducible efficacy and safety in clinical practice tandfonline.com/doi/full/10.10…

Baylor College of Medicine receives more than $17 million from CPRIT #CancerResearch Dan L Duncan Comprehensive Cancer Center Center for Cell and Gene Therapy blogs.bcm.edu/2024/08/22/fro… via BCMHouston

Off to ISEH meeting in Chicago where we will present 3 posters and 3 fabulous talks! Excited to meet old and new friends in hematology. Center for Cell and Gene Therapy From the Labs at Baylor College of Medicine

Excellent results with autologous CD7-PEBL CART in T-ALL from Singapore and Rome nature.com/articles/s4159…

'Hybrid' type of #brain cell can fire electrical signals and may help predict #cancer patient survival. B Deneen, R Curry, A Harmanci, Q Ma, Xiaolong Jiang, Ganesh Rao M.D. Cancer Cell BCMHouston BCM Neurosurgery TCHResearchNews Dan L Duncan Comprehensive Cancer Center Prof Peter Hotez MD PhD houstonchronicle.com/health/article…

An interesting POC of T cell therapy in CNS injury models: autoreactive MOG-specific T cells infiltrate the lesion and suppress tissue damage, counter-intuitively in part via IFNg secretion. But you have to act fast. nature.com/articles/s4158…